aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in Cambridge, United States, Astria Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and commercializing therapeutic treatments for rare diseases and serious lipid disorders. With a mission centered around patient care, Astria Therapeutics aims to bring life-changing therapies to individuals and families affected by allergic and immunological diseases.
Notable figures affiliated with Astria Therapeutics include experts in biopharmaceutical development and rare disease treatment. The company has achieved significant milestones in advancing its clinical pipeline and has garnered attention from key investors in the biotech sector. Astria's impact is marked by its commitment to addressing unmet medical needs and improving the quality of life for patients with rare conditions.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Biopharmaceuticals
Technology
Biotech
Tags
Biotech, Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Astria Therapeutics founded?
Astria Therapeutics was founded in 2008.
Where is Astria Therapeutics’s headquarters located?
Astria Therapeutics’s headquarters is located in Boston, MA, US.
When was Astria Therapeutics’s last funding round?
Astria Therapeutics’s most recent funding round was for $125M (USD) in January 2024.
How many employees does Astria Therapeutics have?
Astria Therapeutics has 24 employees as of Feb 6, 2024.
How much has Astria Therapeutics raised to-date?
As of July 05, 2023, Astria Therapeutics has raised a total of $656.4M (USD) since Jan 30, 2024.
Add Comparison
Total Raised to Date
$656.4M
USD
Last Update Jan 30, 2024
Last Deal Details
$125M
USD
Jan 30, 2024
Post Ipo Equity
Total Employees Over Time
24
As of Feb 2024
Astria Therapeutics Address
75 State Street
Suite 1400
Boston,
Massachusetts
02109
United States of America
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts